Futura Medical (LON:FUM) Shares Down 5.5% – Here’s What Happened

Shares of Futura Medical plc (LON:FUM) dropped 5.5% during trading on Thursday . The company traded as low as GBX 0.64 and last traded at GBX 0.73. Approximately 1,248,722 shares traded hands during trading, a decline of 80% from the average daily volume of 6,124,176 shares. The stock had previously closed at GBX 0.77.

Futura Medical Stock Performance

The company has a market capitalization of £3.60 million, a PE ratio of -0.22 and a beta of 0.01. The stock’s 50 day moving average is GBX 0.95 and its 200 day moving average is GBX 1.12.

Futura Medical (LON:FUM) last announced its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. The business had revenue of GBX 170 million for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. On average, equities research analysts forecast that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.